
Acute ST-Segment Elevation Myocardial Infarction (STEMI)
Oct 6, 2024 · Acute coronary syndrome (ACS) encompasses conditions characterized by a sudden decrease in myocardial perfusion, presenting as ST-segment elevation myocardial infarction (STEMI), non–ST-segment elevation myocardial infarction (NSTEMI), or …
Acute Coronary Syndrome (ACS): Causes, Symptoms & Treatment
Acute coronary syndrome (ACS) is a broad term for three types of coronary artery disease that affect millions of people each year. These potentially life-threatening conditions occur when a blockage causes blood flow to your heart to suddenly slow or stop.
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the …
Feb 27, 2025 · This guideline focuses on the acute management of ACS, including unstable angina, NSTEMI, and STEMI. Video: 2025 Guideline for the Management of Patients With Acute Coronary Syndromes.
2023 ESC Guidelines for the management of acute coronary …
Aug 25, 2023 · This guideline provides a comprehensive overview of the management of patients presenting with Acute coronary syndrome (ACS) from the point of diagnosis and risk stratification at initial presentation, through to long-term management after the initial hospitalisation period.
2025 Acute Coronary Syndromes Guideline-at-a-Glance | JACC
Feb 27, 2025 · In patients with ACS (NSTE-ACS or STEMI) treated with DAPT after BMS or DES implantation, P2Y 12 inhibitor therapy (clopidogrel, prasugrel, or ticagrelor) should be given for at least 12 mo. 6: 1: In patients with ACS who are not at high bleeding risk, DAPT with aspirin and an oral P2Y 12 inhibitor should be administered for at least 1 y to ...
Acute Coronary Syndrome - StatPearls - NCBI Bookshelf
Jul 10, 2023 · Acute coronary syndrome (ACS) refers to a group of conditions that include ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. It is a type of coronary heart disease (CHD), which is responsible for one-third of total deaths in people older than 35.
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the …
Feb 27, 2025 · In randomized placebo-controlled trials in both NSTE-ACS and STEMI, the addition of clopidogrel to aspirin reduced risk of MACE irrespective of management strategy. 1–3 In patients with STEMI treated with fibrinolytic therapy, the addition of clopidogrel to aspirin reduces 30-day MACE, including recurrent MI, and improves survival. 2,3 ...
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the …
Feb 27, 2025 · Affiliations 1 ACC/AHA Joint Committee on Clinical Practice Guidelines liaison.; 2 Lay stakeholder/patient representative.; 3 Society for Cardiovascular Angiography and Interventions representative.; 4 American College of Emergency Physicians representative.; 5 ACC/AHA joint staff representative.; 6 National Association of EMS Physicians representative.; 7 ACC/AHA Joint Committee on ...
ACC/AHA Release New Comprehensive ACS Guidelines
Feb 27, 2025 · Among the new or updated guidance in the document are class 1 recommendations for complete revascularization including the nonculprit arteries for both STEMI and NSTE ACS. Although the 2021 revascularization guidelines recommended doing so in a staged fashion for patients with STEMI, the current document gives a “slight preference” for ...
Acute coronary syndromes | Treatment summaries | BNF | NICE
Acute coronary syndrome (ACS) encompasses a spectrum of conditions which include myocardial infarction with or without ST-segment-elevation (STEMI or NSTEMI respectively), and unstable angina.